NovoCure Limited

NovoCure Limitedverified

NVCR

Price:

$16.59

Market Cap:

$1.80B

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, ...[Read more]

Industry

Medical - Instruments & Supplies

IPO Date

2015-10-01

Stock Exchange

NASDAQ

Ticker

NVCR

The Current Ratio as of November 2024 (TTM) for NovoCure Limited (NVCR) is 1.49

According to NovoCure Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.49. This represents a change of -70.17% compared to the average of 5.00 of the last 4 quarters.

NovoCure Limited (NVCR) Historical Current Ratio (quarterly & annually)

How has NVCR Current Ratio performed in the past?

The mean historical Current Ratio of NovoCure Limited over the last ten years is 6.78. The current 1.49 Current Ratio has changed 2.10% with respect to the historical average. Over the past ten years (40 quarters), NVCR's Current Ratio was at its highest in in the December 2015 quarter at 10.27. The Current Ratio was at its lowest in in the September 2024 quarter at 1.49.

Quarterly (TTM)
Annual

Average

6.78

Median

6.66

Minimum

4.88

Maximum

10.27

NovoCure Limited (NVCR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NovoCure Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 72.58%

Maximum Annual Current Ratio = 10.27

Minimum Annual Increase = -46.20%

Minimum Annual Current Ratio = 4.88

Quarterly (TTM)
Annual
YearCurrent RatioChange
20235.78-17.51%
20227.00-7.01%
20217.53-14.42%
20208.8072.58%
20195.102.40%
20184.981.94%
20174.88-31.23%
20167.10-30.84%
201510.2762.21%
20146.33-46.20%

NovoCure Limited (NVCR) Average Current Ratio

How has NVCR Current Ratio performed in the past?

The current Current Ratio of NovoCure Limited (NVCR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

6.77

5-year avg

6.84

10-year avg

6.78

NovoCure Limited (NVCR) Current Ratio vs. Peers

How is NVCR’s Current Ratio compared to its peers?

NovoCure Limited’s Current Ratio is less than Globus Medical, Inc. (0), less than Insulet Corporation (2.42), less than Inspire Medical Systems, Inc. (3.56), less than Inari Medical, Inc. (9.25), less than TransMedics Group, Inc. (1.77), less than InMode Ltd. (8.20), less than Integer Holdings Corporation (10.68), less than CONMED Corporation (3.28), less than LivaNova PLC (2.27), less than iRhythm Technologies, Inc. (3.37), less than Heska Corporation (6.27), less than ShockWave Medical, Inc. (5.64), less than Penumbra, Inc. (13.81), less than Masimo Corporation (5.82), less than null (2.09),

Build a custom stock screener for NovoCure Limited (NVCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovoCure Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovoCure Limited (NVCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovoCure Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is NovoCure Limited's Current Ratio?

How is the Current Ratio calculated for NovoCure Limited (NVCR)?

What is the highest Current Ratio for NovoCure Limited (NVCR)?

What is the 3-year average Current Ratio for NovoCure Limited (NVCR)?

What is the 5-year average Current Ratio for NovoCure Limited (NVCR)?

How does the current Current Ratio for NovoCure Limited (NVCR) compare to its historical average?